Biology Reference
In-Depth Information
Brodersen, D.E., Clemons, W.M.J., Carter, A.P., Morgan-Warren, R.J., Wimberly, B.T.,
Ramakrishnan, V., 2000. The structural basis for the action of the antibiotics tetracy-
cline, pactamycin, and hygromycin B on the 30S ribosomal subunit. Cell 103, 1143-
1154.
Broekhuysen, J., Stockis, A., Lins, R.L., De Graeve, J., Rossignol, J.F., 2000. Nitazoxanide:
pharmacokinetics and metabolism in man. Int. J. Clin. Pharmacol. Ther. 38, 387-394.
Busatti, H.G., Gomes, M.A., 2007. A simple colourimetric method to determine anti-giar-
dial activity of drugs. Parasitol. Res. 101, 819-821.
Cassell, G.H., Mekalanos, J., 2001. Development of antimicrobial agents in the era of new and
reemerging infectious diseases and increasing antibiotic resistance. JAMA 285, 601-605.
Chen, C.Z., Kulakova, L., Southall, N., Marugan, J.J., Galkin, A., Austin, C.P., Herzberg, O.,
Zheng, W., 2011. High-throughput
Giardia lamblia
viability assay using bioluminescent
ATP content measurements. Antimicrob. Agents Chemother. 55, 667-675.
Chen, F., Cushion, M.T., 1994. Use of an ATP bioluminescent assay to evaluate viability of
Pneumocystis carinii
from rats. J. Clin. Microbiol. 32, 2791-2800.
Chilengi, R., Gitaka, J., 2010. Is vaccine the magic bullet for malaria elimination? A reality
check. Malar. J. 9 (Suppl. 3), S1.
Ciak, J., Hahn, F.E., 1967. Quinacrine (atebrin): mode of action. Science 156, 655-656.
Cortes, H.C., Mueller, N., Esposito, M., Leitão, A., Naguleswaran, A.,A.,H., 2007. In vitro
efficacy of nitro- and bromo-thiazolyl-salicylamide compounds (thiazolides) against
Bes-
noitia besnoiti
infection in Vero cells. Parasitology 134, 975-985.
Cos, P., Vlietinck, A.J., Berghe, D.V., Maes, L., 2006. Anti-infective potential of natural prod-
ucts: how to develop a stronger in vitro 'proof-of-concept'. J. Ethnopharmacol. 106,
290-302.
Cui, L., Miao, J., Wang, J., Li, Q., Cui, L., 2008.
Plasmodium falciparum
: development of a
transgenic line for screening antimalarials using firefly luciferase as the reporter. Exp.
Parasitol. 120, 80-87.
Cui, L., Su, X.Z., 2009. Discovery, mechanisms of action and combination therapy of arte-
misinin. Expert Rev. Anti Infect. Ther. 7, 999-1013.
Cunningham, E., Drag, M., Kafarski, P., Bell, A., 2008. Chemical target validation studies of
aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phospho-
nopeptide inhibitors. Antimicrob. Agents Chemother. 52, 3221-3228.
Dahl, E.L., Rosenthal, P.J., 2008. Apicoplast translation, transcription and genome replication:
targets for antimalarial antibiotics. Trends Parasitol. 24, 279-284.
Darkin-Rattray, S.J., Gurnett, A.M., Myers, R.W., Dulski, P.M., Crumley, T.M., Allocco, J.J.,
Cannova, C., Meinke, P.T., Colletti, S.L., Bednarek, M.A., Singh, S.B., Goetz, M.A.,
Dombrowski, A.W., Polishook, J.D., Schmatz, D.M., 1996. Apicidin: a novel antipro-
tozoal agent that inhibits parasite histone deacetylase. Proc. Natl. Acad. Sci. U.S.A. 93,
13143-13147.
Datta, A.K., Datta, R., Sen, B., 2008. Antiparasitic chemotherapy: tinkering with the purine
salvage pathway. Adv. Exp. Med. Biol. 625, 116-132.
Debache, K., Guionaud, C., Kropf, C., Boykin, D., Stephens, C.E., Hemphill, A., 2011.
Experimental treatment of
Neospora caninum
-infected mice with the arylimidamide
DB750 and the thiazolide nitazoxanide. Exp. Parasitol. 129, 95-100.
Derbyshire, E.T., Franssen, F.J., de Vries, E., Morin, C., Woodrow, C.J., Krishna, S., Staines,
H.M., 2008. Identification, expression and characterisation of a
Babesia bovis
hexose
transporter. Mol. Biochem. Parasitol. 161, 124-129.
Desjardins, R.E., Canfield, C.J., Haynes, J.D., Chulay, J.D., 1979. Quantitative assessment of
antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob.
Agents Chemother. 16, 710-718.
Di Paola, M., Lorusso, M., 2006. Interaction of free fatty acids with mitochondria: coupling,
uncoupling and permeability transition. Biochim. Biophys. Acta 1757, 1330-1337.
Search WWH ::
Custom Search